CClinicalTrials.gg
CompletedNCT05256966Updated Jul 15, 2025

Firefighter Soot, Sauna, and Sweat Excretion Pilot Study

An interventional study of Sauna (steam) in Cancer, sponsored by HealthPartners Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-15.

Sponsored by HealthPartners Institute · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to evaluate whether sauna use after active-duty firefighting is effective in reducing exposure to certain harmful chemicals called polycyclic aromatic hydrocarbons (PAHs). PAHs are found in soot and several types are known to be carcinogens.

This study is a cross-sectional pilot study that will be performed in active-duty firefighters. The firefighters will be subdivided into those who will use a sauna immediately after fighting a fire versus those who will not, the latter of which will serve as a metabolism control group. There will thus be two comparison groups within the study: 1) active-duty firefighters using a sauna after fire suppression (sauna group); 2) active-duty firefighters not using a sauna after fire suppression (metabolism control).

Read the detailed description

Study Rationale

Firefighters are exposed to toxic materials during fire suppression activities and have a higher rate of cancer than the general population, despite a high level of physical fitness. Some studies suggest the use of sauna (infrared or traditional) may increase excretion of harmful and toxic chemicals. Biomonitoring is the measure of chemicals or metabolites present in the human body and is used to evaluate exposure. This proposed study is a biomonitoring pilot study to evaluate the effectiveness of use of a sauna at modulating excretion of select classes of chemicals from firefighters.

One of the most well-established occupational hazards to firefighters is soot, the black particulate matter generated during combustion of organic materials. The chemical composition of soot varies based on the original material undergoing combustion, but the primary organic components of soot comprises a class of compounds known as polycyclic aromatic hydrocarbons (PAHs), which includes many carcinogens.3 PAH exposure can be measured through the analysis of hydroxy metabolites (OH-PAHs) in urine, the methods of which are well-established and have been conducted in the general population and in firefighters in several studies.4-6 The existing literature evaluating excretion of compounds via sweat is suggestive that some compounds may be more quickly eliminated by inducing sweating, such as via use of the sauna. There is a lack of standardization in sweat biomonitoring and further development of these methods is still needed.15 This proposed pilot study will contribute to the biomonitoring literature particularly in the firefighting population by addressing the gaps in knowledge of whether PAHs are excreted in sweat, and whether use of a sauna can affect rates of PAH excretion in firefighters.

Study Objective(s)

Aim 1. This study aims to demonstrate that sauna use immediately after active-duty firefighting will result in measurable (above the level of detection) PAH biomarkers in sweat.

Aim 2. This study secondarily aims to demonstrate that sauna use immediately after active-duty firefighting will result in significantly different mean levels of PAH biomarkers in urine as compared to no use of a sauna.

Study Design

This study is a cross-sectional pilot study that will be performed in active-duty firefighters. The firefighters will be subdivided into those who will use a sauna immediately after fighting a fire versus those who will not, the latter of which will serve as a metabolism control group. There will thus be two comparison groups within the study: 1) active-duty firefighters using a sauna after fire suppression (sauna group); 2) active-duty firefighters not using a sauna after fire suppression (metabolism control).

Subject Population

This study's population is established based on convenience, as the St. Paul Fire Department already has a single station where a sauna has been installed for several decades. The study intervention population will include St. Paul Firefighters working within Station 4, the only station at present where a sauna is installed. The metabolism control group will include St. Paul Firefighters working in stations 7 and 17, who may be called to actively perform at the same fires as the firefighters at Station 4.

St. Paul Firefighters work full-time, on 24-hour shifts, with three different shifts delineated. Station 4 comprises 9 firefighters across 3 shifts, totaling 27 firefighters. The study will be opened to all firefighters in the St. Paul Fire Department, and the Department Chief and department staff will work to schedule individuals enrolled into the study to work at Station 4, 7, or 17.

Inclusion criteria:

  1. Willingness to collect urine samples before, during, and/or after work shift
  2. Willingness to refrain from eating barbecued or smoked foods during the duration of the study
  3. Willingness to use a sauna after active fire suppression and to collect sweat samples at that time

Exclusion criteria:

  1. Declined participation in the study
  2. Unwilling or do not agree to complete all data collection components of the study
  3. Limited from active-duty firefighting (regardless of reason)
  4. Medical conditions precluding the use of a sauna
  5. Pregnancy (as sauna use is contraindicated in pregnancy)

Number Of Subjects

A minimum of 20 people (10 per group) and a maximum of 60 people (30 per group) will be recruited. As this is a convenience sample, and as not all possible individuals within each sample subpopulation may opt to participate in this study, these samples may be drawn from the same individuals after different active fire runs. Each participant may be asked to provide biosamples up to four times.

The sauna group will comprise 30 urine and 30 sweat samples, whereas the metabolism control group will comprise 30 urine samples, totaling 90 study samples for analysis. The study sample size is limited on resources available for conducting this study and processing samples, and is not intended to meet statistical significance as much as demonstrate differential exposures to PAHs and metabolism of PAHs in the context of this pilot study.

Study Duration

Each subject will be asked to contribute biosamples up to four times. The biosample collection phase is expected to last approximately three months.

The entire study is expected to last 12 months. Study Phases

  1. Screening: screening for eligibility and obtaining consent
  2. Enrollment: Collection of demographic info and instruction on sample collection
  3. Data Collection: Participants collect bio-samples
  4. Analysis: MDH analyses of lab samples; statistical analysis to determine study outcomes
  5. Results: results provided to participants and analyzed to determine study results
  6. Publication: writing and publication of manuscript Statistical And Analytic Plan Statistical testing will comprise a two-tailed t-test (or non-parametric equivalent test if conditions of normality are not met), where statistical significance will be considered at a p-value of \<= 0.05.

Aim 1. Detection of PAH parent compounds and metabolites in sweat. Number of detections will be descriptively reported in addition to means and standard deviations of those samples above the report levels.

Aim 2. Comparison of urine PAH biomarkers in sauna group versus metabolism control group. A statistical test of means will be performed on the mean levels of urine PAH biomarkers in the sauna group and the metabolism control group.

The Investigators will use a chi-square test to compare the baseline characteristics of the two groups. If the investigators find a significant difference, the investigators will plan on adjusting for the role of the participant in analysis. Similarly, if the investigators find other baseline characteristic(s) to significantly differ between groups, the investigators will adjust for those variables using multivariate regression that includes treatment group as a variable (Sauna, Metabolism) along with the variables that are unbalanced between the groups.

Statistical analysis will be conducted by the principal investigator (Dr. Zeke McKinney) with the assistance of the Research Methodology Group at the HealthPartners Institute.

02

Conditions studied

  • Cancer

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 86 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

HealthPartners Institute is the lead sponsor of 164 studies on the registry; 20 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 16 (94%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Willingness to collect urine samples before, during, and/or after work shift
  2. Willingness to refrain from eating barbecued or smoked foods during the duration of the study
  3. Willingness to use a sauna after active fire suppression and to collect sweat samples at that time

Exclusion criteria

Exclusion Criteria:

  1. Declined participation in the study
  2. Unwilling or do not agree to complete all data collection components of the study
  3. Limited from active-duty firefighting (regardless of reason)
  4. Medical conditions precluding the use of a sauna
  5. Pregnancy (as sauna use is contraindicated in pregnancy)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (actual)

Study arms

  • Active comparator
    Sauna

    Firefighters/participants based at the station with an existing sauna will be allocated to the intervention arm/sauna group. They will include a sauna session, as per study protocol, which is the intervention.

    Other: Sauna (steam)

  • No intervention
    Non Sauna

    Firefighters/participants based at the stations without a sauna will be allocated to the control arm/Non sauna group. They will not sauna, as per study protocol, as to not receive the study intervention.

Interventions

  • OtherSauna (steam)

    Steam Sauna

06

What researchers measure

Primary outcomes

  1. Change of PAHs present in sweat

    This study aims to demonstrate that sauna use immediately after active-duty firefighting will result in a change of PAH biomarkers measurable in sweat.

    Time frame: Through study completion, when 90 matched samples have been collected

Secondary outcomes

  1. Change in PAHs present in urine

    This study secondarily aims to demonstrate that sauna use immediately after active-duty firefighting will result in significantly changed mean levels of PAH biomarkers in urine as compared to no use of a sauna.

    Time frame: Through study completion, when 90 matched samples have been collected

07

Study locations

1 site
  • HealthPartners Institute
    Minneapolis, Minnesota 55403, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05256966
Lead sponsor
HealthPartners Institute
Collaborators
Minnesota Department of Health
Responsible party
Sponsor
First posted
Feb 25, 2022
Start date
Nov 1, 2021
Primary completion
May 30, 2024
Completion
May 30, 2024
Last update
Jul 15, 2025

Study contacts

Zeke McKinney, MD
principal investigator · HealthPartners Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion